Molecular medicine in the US: can three paradigms shift simultaneously?

Ethical issues in cystic fibrosis newborn screening: from data to public health policy.

Current opinion in pulmonary medicine·2002

Conflict of interest policies in science and medical journals: editorial practices and author disclosures.

Science and engineering ethics·2001

Increased capacity may exacerbate rationing problems: with applications to medical care.

Journal of health economics·2000

Scientific journals and their authors' financial interests: a pilot study.

Psychotherapy and psychosomatics·1998

Financial interest and its disclosure in scientific publications.

JAMA·1998

Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes.

Circulation·1997

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Development of a Novel, Eco-Friendly Mechanical Cell Lysis Process Using Hollow Fiber Filter for AAV Manufacturing.

Biotechnology and bioengineering·2026

Programmed repair of disease-causing UGA premature termination codons in mammalian brain.

Nucleic acids research·2026

Case Report: Novel homozygous pathogenic variant of the SPG20 gene causes the Troyer syndrome in China.

Frontiers in genetics·2026

Molecular profiling and functional analyses of umbilical cord mesenchymal stem cell-derived extracellular vesicles for dry eye diseases.

Extracellular vesicles and circulating nucleic acids·2026

Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives.

Frontiers in immunology·2026

Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.

The Journal of clinical and aesthetic dermatology·2026

Related Experiment Videos

Molecular medicine in the US: can three paradigms shift simultaneously?

Related Concept Videos

Ethical issues in cystic fibrosis newborn screening: from data to public health policy.

Conflict of interest policies in science and medical journals: editorial practices and author disclosures.

Increased capacity may exacerbate rationing problems: with applications to medical care.

Scientific journals and their authors' financial interests: a pilot study.

Financial interest and its disclosure in scientific publications.

Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Development of a Novel, Eco-Friendly Mechanical Cell Lysis Process Using Hollow Fiber Filter for AAV Manufacturing.

Programmed repair of disease-causing UGA premature termination codons in mammalian brain.

Case Report: Novel homozygous pathogenic variant of the SPG20 gene causes the Troyer syndrome in China.

Molecular profiling and functional analyses of umbilical cord mesenchymal stem cell-derived extracellular vesicles for dry eye diseases.

Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives.

Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.

Related Experiment Videos

Molecular medicine in the US: can three paradigms shift simultaneously?

Related Concept Videos

Related Articles